ArticleNeurosurgical review2026
Early postoperative seizure after extracranial-intracranial revascularization for moyamoya disease and moyamoya syndrome: single centre post-revascularization moyamoya cohort study in Indonesia.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early postoperative seizure after revascularization for moyamoya vasculopathy remains incompletely characterized, particularly in Indonesia. This study described the incidence and exploratory clinical and hemodynamic patterns associated with early postoperative seizure after extracranial-intracranial bypass in an Indonesian single center cohort. This single center retrospective cohort included moyamoya disease (MMD) or moyamoya syndrome (MMS) patients who underwent extracranial-intracranial revascularization. Early postoperative seizure was defined as a clinically documented new onset epileptic event occurring intraoperatively after bypass completion or within 14 days. Clinical and computed tomography perfusion (CTP) variables were compared between MMD and MMS and, within MMS, between seizure and non-seizure groups using descriptive exploratory analyses. Forty patients were analyzed, including 19 with MMD and 21 with MMS. Early postoperative seizure occurred exclusively in the MMS group (6/21, 29%) and was not observed in MMD (0/19; p = 0.021). Compared with MMS, MMD demonstrated larger pre-bypass infarct volume (14.48 ± 8.54 vs. 5.06 ± 5.52 mL; p = 0.005) and hypoperfusion volume (54.39 ± 33.07 vs. 27.26 ± 25.76 mL; p = 0.028). In paired CTP analysis, hypoperfusion volume decreased from 41.48 ± 27.78 to 26.06 ± 21.51 mL (p = 0.023), and infarct volume decreased from 10.27 ± 7.89 to 5.48 ± 4.16 mL (p = 0.040). Within MMS, patients with postoperative seizure were older (52.00 [41.75 to 55.00] vs. 35.00 [26.00 to 42.00] years; p = 0.014), more frequently presented with dysarthria (67% vs. 20%; p = 0.040) and monoparesis (50% vs. 0%; p = 0.015), and were more commonly classified as having suspected atherosclerotic vasculopathy (100% vs. 33.3%; p = 0.012). Follow up CTP demonstrated lower relative post-bypass CBV in the seizure group (0.31 [0.14 to 0.48] vs. 1.16 [0.68 to 1.22]; p = 0.026), although this finding was interpreted cautiously because postoperative imaging was not temporally aligned with seizure onset. In this exploratory Indonesian moyamoya cohort, early postoperative seizures were observed only in the MMS subgroup. Older age, baseline focal neurological deficits, and MMS related etiologic heterogeneity may be relevant to postoperative seizure susceptibility.
Indexed as
Identifiers
42481904What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.